Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

USA - NYSE:BMI - US0565251081 - Common Stock

183.08 USD
+1.15 (+0.63%)
Last: 11/4/2025, 8:04:00 PM
183.08 USD
0 (0%)
After Hours: 11/4/2025, 8:04:00 PM
Fundamental Rating

7

Overall BMI gets a fundamental rating of 7 out of 10. We evaluated BMI against 124 industry peers in the Electronic Equipment, Instruments & Components industry. BMI gets an excellent profitability rating and is at the same time showing great financial health properties. BMI is quite expensive at the moment. It does show a decent growth rate. With these ratings, BMI could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

BMI had positive earnings in the past year.
BMI had a positive operating cash flow in the past year.
In the past 5 years BMI has always been profitable.
BMI had a positive operating cash flow in each of the past 5 years.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

BMI's Return On Assets of 14.19% is amongst the best of the industry. BMI outperforms 92.74% of its industry peers.
BMI has a Return On Equity of 19.75%. This is amongst the best in the industry. BMI outperforms 88.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.43%, BMI belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
BMI had an Average Return On Invested Capital over the past 3 years of 15.23%. This is significantly above the industry average of 9.51%.
The 3 year average ROIC (15.23%) for BMI is below the current ROIC(16.43%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROIC 16.43%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

BMI has a Profit Margin of 15.40%. This is amongst the best in the industry. BMI outperforms 93.55% of its industry peers.
BMI's Profit Margin has improved in the last couple of years.
BMI's Operating Margin of 19.93% is amongst the best of the industry. BMI outperforms 96.77% of its industry peers.
In the last couple of years the Operating Margin of BMI has grown nicely.
BMI has a better Gross Margin (41.26%) than 70.16% of its industry peers.
In the last couple of years the Gross Margin of BMI has remained more or less at the same level.
Industry RankSector Rank
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

BMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BMI has been increased compared to 1 year ago.
The number of shares outstanding for BMI has been increased compared to 5 years ago.
There is no outstanding debt for BMI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BMI has an Altman-Z score of 14.58. This indicates that BMI is financially healthy and has little risk of bankruptcy at the moment.
BMI has a better Altman-Z score (14.58) than 91.94% of its industry peers.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.58
ROIC/WACC1.78
WACC9.21%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BMI has a Current Ratio of 3.22. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI has a Current ratio of 3.22. This is in the better half of the industry: BMI outperforms 66.13% of its industry peers.
BMI has a Quick Ratio of 2.23. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI has a better Quick ratio (2.23) than 62.10% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.23
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.63% over the past year.
BMI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.16% yearly.
The Revenue has grown by 12.11% in the past year. This is quite good.
The Revenue has been growing by 14.25% on average over the past years. This is quite good.
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.18% yearly.
BMI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.30% yearly.
EPS Next Y13.79%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
EPS Next 5Y12.18%
Revenue Next Year12.3%
Revenue Next 2Y10.4%
Revenue Next 3Y8.55%
Revenue Next 5Y9.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 38.95, the valuation of BMI can be described as expensive.
BMI's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.03. BMI is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 33.81, BMI can be considered very expensive at the moment.
BMI's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BMI to the average of the S&P500 Index (22.27), we can say BMI is valued expensively.
Industry RankSector Rank
PE 38.95
Fwd PE 33.81
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BMI's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, BMI is valued a bit cheaper than 71.77% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.44
EV/EBITDA 24.33
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BMI does not grow enough to justify the current Price/Earnings ratio.
BMI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.83
PEG (5Y)1.84
EPS Next 2Y13.14%
EPS Next 3Y10.48%

6

5. Dividend

5.1 Amount

BMI has a yearly dividend return of 0.88%, which is pretty low.
BMI's Dividend Yield is rather good when compared to the industry average which is at 2.06. BMI pays more dividend than 84.68% of the companies in the same industry.
With a Dividend Yield of 0.88, BMI pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.88%

5.2 History

The dividend of BMI is nicely growing with an annual growth rate of 13.80%!
BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
BMI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.8%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BMI pays out 30.10% of its income as dividend. This is a sustainable payout ratio.
BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.1%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (11/4/2025, 8:04:00 PM)

After market: 183.08 0 (0%)

183.08

+1.15 (+0.63%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-21 2025-10-21/bmo
Earnings (Next)01-29 2026-01-29/amc
Inst Owners99.93%
Inst Owner Change-1.29%
Ins Owners0.51%
Ins Owner Change-0.18%
Market Cap5.40B
Revenue(TTM)901.14M
Net Income(TTM)138.78M
Analysts73.33
Price Target226.96 (23.97%)
Short Float %6.24%
Short Ratio4.8
Dividend
Industry RankSector Rank
Dividend Yield 0.88%
Yearly Dividend1.22
Dividend Growth(5Y)13.8%
DP30.1%
Div Incr Years18
Div Non Decr Years18
Ex-Date08-22 2025-08-22 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.02%
Min EPS beat(2)-7.6%
Max EPS beat(2)3.55%
EPS beat(4)2
Avg EPS beat(4)2.98%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)5
Avg EPS beat(8)4.65%
EPS beat(12)8
Avg EPS beat(12)6.34%
EPS beat(16)11
Avg EPS beat(16)6.98%
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)0.62%
Revenue beat(4)2
Avg Revenue beat(4)0.04%
Min Revenue beat(4)-0.51%
Max Revenue beat(4)0.62%
Revenue beat(8)4
Avg Revenue beat(8)1.08%
Revenue beat(12)8
Avg Revenue beat(12)2.82%
Revenue beat(16)11
Avg Revenue beat(16)2.84%
PT rev (1m)-4.33%
PT rev (3m)-4.64%
EPS NQ rev (1m)1.74%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)-3.86%
Revenue NQ rev (1m)-1.57%
Revenue NQ rev (3m)-1.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE 38.95
Fwd PE 33.81
P/S 5.99
P/FCF 32.44
P/OCF 29.81
P/B 7.68
P/tB 15.69
EV/EBITDA 24.33
EPS(TTM)4.7
EY2.57%
EPS(NY)5.41
Fwd EY2.96%
FCF(TTM)5.64
FCFY3.08%
OCF(TTM)6.14
OCFY3.35%
SpS30.58
BVpS23.84
TBVpS11.67
PEG (NY)2.83
PEG (5Y)1.84
Graham Number50.21
Profitability
Industry RankSector Rank
ROA 14.19%
ROE 19.75%
ROCE 21.77%
ROIC 16.43%
ROICexc 21.75%
ROICexgc 51.26%
OM 19.93%
PM (TTM) 15.4%
GM 41.26%
FCFM 18.45%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
ROICexc(3y)23.61%
ROICexc(5y)20.43%
ROICexgc(3y)41.01%
ROICexgc(5y)36.17%
ROCE(3y)20.17%
ROCE(5y)18.85%
ROICexgc growth 3Y15.78%
ROICexgc growth 5Y16.08%
ROICexc growth 3Y21.65%
ROICexc growth 5Y15.12%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 43.31%
Cap/Sales 1.63%
Interest Coverage 250
Cash Conversion 84.78%
Profit Quality 119.84%
Current Ratio 3.22
Quick Ratio 2.23
Altman-Z 14.58
F-Score5
WACC9.21%
ROIC/WACC1.78
Cap/Depr(3y)34.99%
Cap/Depr(5y)33.03%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.55%
Profit Quality(3y)111.64%
Profit Quality(5y)126.18%
High Growth Momentum
Growth
EPS 1Y (TTM)16.63%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%10.19%
EPS Next Y13.79%
EPS Next 2Y13.14%
EPS Next 3Y10.48%
EPS Next 5Y12.18%
Revenue 1Y (TTM)12.11%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%13.06%
Revenue Next Year12.3%
Revenue Next 2Y10.4%
Revenue Next 3Y8.55%
Revenue Next 5Y9.3%
EBIT growth 1Y19.1%
EBIT growth 3Y26.12%
EBIT growth 5Y20.53%
EBIT Next Year36.93%
EBIT Next 3Y16.39%
EBIT Next 5Y15.62%
FCF growth 1Y83.29%
FCF growth 3Y20.76%
FCF growth 5Y14.2%
OCF growth 1Y77.62%
OCF growth 3Y21%
OCF growth 5Y13.95%

BADGER METER INC / BMI FAQ

What is the fundamental rating for BMI stock?

ChartMill assigns a fundamental rating of 7 / 10 to BMI.


What is the valuation status of BADGER METER INC (BMI) stock?

ChartMill assigns a valuation rating of 3 / 10 to BADGER METER INC (BMI). This can be considered as Overvalued.


Can you provide the profitability details for BADGER METER INC?

BADGER METER INC (BMI) has a profitability rating of 9 / 10.


What are the PE and PB ratios of BADGER METER INC (BMI) stock?

The Price/Earnings (PE) ratio for BADGER METER INC (BMI) is 38.95 and the Price/Book (PB) ratio is 7.68.


Can you provide the dividend sustainability for BMI stock?

The dividend rating of BADGER METER INC (BMI) is 6 / 10 and the dividend payout ratio is 30.1%.